Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Amino-6-chlorobenzene-1-sulfonamide is a sulfonamide that inhibits the ATP sensitive potassium channel. It is used as a muscle relaxant and to treat muscle spasms. 2-Amino-6-chlorobenzene-1-sulfonamide has been shown to have an inhibitory effect on the chlorine atom of ATP sensitive potassium channels in vitro, which may lead to vasorelaxation through the opening of potassium channels. This drug has also been shown to be more potent than other drugs with similar effects, such as heptaminol and diazoxide. In addition, this drug has a low toxicity profile.</p>

<p>3,4-Dimethylthiophene-2-carboxylic acid is an experimental compound that has been shown to be a linear molecule with a molecular weight of 144. The experimental equation for the formation of 3,4-dimethylthiophene-2-carboxylic acid from 3,4-dimethoxythiophene and acetic acid is:</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Chlorobenzylsulfonamide is a drug that binds to the receptor for neutral lipids, which is found on the surface of human fibroblasts. This binding inhibits the release of free fatty acids from adipose tissue and also prevents the uptake of these lipids by tissues such as muscle. 2-Chlorobenzylsulfonamide has been shown to be effective at reducing hyperlipidemia in mice. This drug has a limited effect on heparin-induced lipoprotein lipase activity in vivo, but it does have an antidiabetic effect on rats when given orally. The mechanism of this effect may be due to its ability to inhibit lipolysis or to activate lipoprotein lipase.</p>

<p>Versatile small molecule scaffold</p>

<p>Isbogrel is a pharmaceutical preparation that belongs to the group of fatty acids. It has been shown to be effective in the treatment of inflammatory bowel disease, and has also been shown to have anti-platelet properties. Isbogrel is an analog of the natural product arachidonic acid, which is synthesized from linoleic acid through the activity of enzymes called phospholipase A2 (PLA2). Isbogrel inhibits prostaglandin synthesis by binding to and inhibiting PLA2, thereby preventing arachidonic acid production. Isbogrel may also be used for the prevention and treatment of myocardial infarcts due to its ability to reduce blood pressure and improve symptoms.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1-Methyl-2-oxopyrrolidine-4-carboxamide is a bioactive molecule found in leaves. It was isolated by GC–MS analysis and identified by comparison of its retention time with the standard toluene, formic acid, and formaldehyde. 1-Methyl-2-oxopyrrolidine-4-carboxamide has shown to have antiinflammatory properties. Quantitative analysis of this molecule showed that it is present at 0.1% of the leaf extract.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Hydroxy-6-iodobenzoic acid is a synthetic salicylate that has been shown to inhibit the x-ray induced release of catecholamines from chromaffin cells. It also inhibits the ATPase activity of V-ATPase in mouse granulosa cells, which may be due to its ability to inhibit phosphorylation at Ser/Thr residues. 2-Hydroxy-6-iodobenzoic acid has also been shown to have antitumor properties and to inhibit the growth of both leukemia and lymphoma cells. The natural product is an inhibitor of protein synthesis, as well as a potent antimicrobial agent. Its structure consists of a macrolide fused with a quinoline ring system. It is an effective inhibitor of bacterial protein synthesis and can be used as a starting material for the synthesis of other compounds that are structurally similar to 2HIB.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Etoricoxib is a nonsteroidal anti-inflammatory drug that is marketed for the relief of osteoarthritis and rheumatoid arthritis. Etoricoxib is an inhibitor of cyclooxygenase-2, which is involved in the inflammatory response. It also inhibits the activity of lipoxygenases, which are enzymes that oxidize fatty acids to form leukotrienes. Etoricoxib has been found to be a potent inhibitor of cytochrome P450 (CYP) 2C9, CYP2C19, CYP2D6 and CYP3A4. Etoricoxib was also found to bind to DNA in calf thymus tissue with high affinity. This binding may inhibit transcription or replication.</p>

<p>Isoxazolo[5,4-c]pyridin-3-amine is an inhibitor of fatty acid amide hydrolase (FAAH), a metabolic enzyme that catalyzes the hydrolysis of the endogenous fatty acid amides. This inhibition results in increased levels of endocannabinoids, which are known to reduce pain and inflammation. Isoxazolo[5,4-c]pyridin-3-amine has been shown to be effective against a number of FAAH inhibitors, including other inhibitors such as URB597 and JZL184. These compounds have also been shown to produce analgesic effects in mice by inhibiting the production of proinflammatory cytokines such as tumor necrosis factor α (TNFα) and IL-1β.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>7-Chloroindoline is a cyclohexanone derivative that has shown in vitro activity against b. subtilis and S. aureus. It has antimicrobial properties and is classified as an antimicrobial agent. 7-Chloroindoline has been shown to inhibit the growth of bacteria by binding to their DNA, preventing RNA synthesis and protein production. The mechanism of action is similar to the other cyclohexanones, but the antimicrobial properties are not as potent. 7-Chloroindoline also shows antifungal activity against Candida albicans, Coccidioides immitis, and Cryptococcus neoformans.</p>

<p>Versatile small molecule scaffold</p>

<p>Paliperidone is an antipsychotic drug that belongs to the group of thiophenylpiperazines. It is used in the treatment of schizophrenia and bipolar disorder, as well as in the prevention of psychosis in people with a history of such disorders. Paliperidone has been shown to be effective for treating psychotic symptoms in children. This drug is also effective for preventing cancer by inhibiting cell growth and inducing apoptosis. Paliperidone has been shown to have long-term safety and low toxicity levels, with no increase in the risk of death or cancer.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Amino-4-bromopyridin-3-ol is an organometallic compound that is synthesized from benzyl alcohol and 2-chloro-5 nitrobenzaldehyde. It has a molecular weight of 263.2 g/mol and a melting point of 171 degrees Celsius. The compound has been observed as a white crystalline powder with a melting point range of 119 to 173 degrees Celsius. The compound exhibits electron microscopy morphology, which is spherical in shape with a size range of 1 to 10 nm. 2-Amino-4 bromopyridin-3-ol has been shown to be selective for the benzyl alcohol substrate, yielding high yields of up to 98%.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Bromo-alpha-methylbenzyl alcohol is a chiral molecule that has two enantiomers, which are mirror images of each other. The (S)-(+)-enantiomer is the active form and the (R)-(-)-enantiomer has no biological activity. 2-Bromo-alpha-methylbenzyl alcohol can be hydrogenated to form (+) -2-bromo-alpha-methylbenzaldehyde, which is an allylic compound with a conjugate diastereomeric relationship to it. This means that the two enantiomers have different chemical properties because they are structurally related in a way that does not allow for rotation about a single bond. The (S)-(+)-enantiomer of 2-bromo-alpha-methylbenzyl alcohol exhibits high affinity for phosphorus ligands, while the (R)-(-)-enantiomer has no affinity.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Temozolomide is an organic compound with a nitro group at the 8-position. It is used as a cytotoxic agent to treat cancer. Temozolomide has been shown to yield high yields of up to 98% when synthesized in acidic conditions, such as hydrochloric acid and methyl isocyanate. This compound can also be synthesized in basic ph conditions using carbamate chemistry. The sensitivity of this compound to nitrophenyl, nitrite, and chloride can be used to determine its purity. Organic synthesis of temozolomide requires an understanding of organic chemistry principles and the use of basic laboratory equipment such as a vacuum pump, a glassware set, and a drying oven.</p>

<p>Versatile small molecule scaffold</p>